NeuroMetrix Price to Free Cash Flow Ratio 2010-2024 | NURO
Historical price to free cash flow ratio values for NeuroMetrix (NURO) since 2010.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| NeuroMetrix Price to Free Cash Flow Ratio Historical Data |
| Date |
Stock Price |
TTM FCF per Share |
Price to FCF Ratio |
| 2025-05-01 |
4.58 |
|
0.00 |
| 2024-12-31 |
3.97 |
$-3.62 |
0.00 |
| 2024-09-30 |
3.97 |
$-4.12 |
0.00 |
| 2024-06-30 |
3.69 |
$-5.13 |
0.00 |
| 2024-03-31 |
4.25 |
$-6.00 |
0.00 |
| 2023-12-31 |
3.60 |
$-6.02 |
0.00 |
| 2023-09-30 |
5.73 |
$-6.08 |
0.00 |
| 2023-06-30 |
7.80 |
$-6.76 |
0.00 |
| 2023-03-31 |
11.76 |
$-6.27 |
0.00 |
| 2022-12-31 |
11.92 |
$-5.97 |
0.00 |
| 2022-09-30 |
22.32 |
$-5.50 |
0.00 |
| 2022-06-30 |
29.44 |
$-4.02 |
0.00 |
| 2022-03-31 |
33.28 |
$-4.20 |
0.00 |
| 2021-12-31 |
40.16 |
$-3.45 |
0.00 |
| 2021-09-30 |
81.12 |
$-2.84 |
0.00 |
| 2021-06-30 |
27.28 |
$-1.85 |
0.00 |
| 2021-03-31 |
27.28 |
$-1.41 |
0.00 |
| 2020-12-31 |
25.28 |
$-5.49 |
0.00 |
| 2020-09-30 |
13.60 |
$-5.84 |
0.00 |
| 2020-06-30 |
16.40 |
$-19.04 |
0.00 |
| 2020-03-31 |
9.09 |
$-36.92 |
0.00 |
| 2019-12-31 |
34.40 |
$-30.33 |
0.00 |
| 2019-09-30 |
25.60 |
$-33.74 |
0.00 |
| 2019-06-30 |
32.80 |
$-18.15 |
0.00 |
| 2019-03-31 |
88.00 |
$6.09 |
14.45 |
| 2018-12-31 |
60.80 |
$15.66 |
3.88 |
| 2018-09-30 |
106.40 |
$-207.38 |
0.00 |
| 2018-06-30 |
104.80 |
$-176.43 |
0.00 |
| 2018-03-31 |
112.80 |
$-322.54 |
0.00 |
| 2017-12-31 |
138.32 |
$-602.56 |
0.00 |
| 2017-09-30 |
163.20 |
$-964.84 |
0.00 |
| 2017-06-30 |
215.20 |
$-1,314.86 |
0.00 |
| 2017-03-31 |
396.80 |
$-1,731.32 |
0.00 |
| 2016-12-31 |
472.70 |
$-2,033.83 |
0.00 |
| 2016-09-30 |
998.40 |
$-2,512.13 |
0.00 |
| 2016-06-30 |
1062.40 |
$-2,485.98 |
0.00 |
| 2016-03-31 |
1171.20 |
$-2,921.48 |
0.00 |
| 2015-12-31 |
1267.20 |
$-3,223.07 |
0.00 |
| 2015-09-30 |
2259.20 |
$-3,288.10 |
0.00 |
| 2015-06-30 |
2328.06 |
$-3,289.98 |
0.00 |
| 2015-03-31 |
4300.80 |
$-3,078.34 |
0.00 |
| 2014-12-31 |
4992.00 |
$-2,902.05 |
0.00 |
| 2014-09-30 |
4608.00 |
$-1,776.44 |
0.00 |
| 2014-06-30 |
4966.40 |
$-1,484.33 |
0.00 |
| 2014-03-31 |
5990.40 |
$-704.30 |
0.00 |
| 2013-12-31 |
7475.20 |
$-9.28 |
0.00 |
| 2013-09-30 |
4224.00 |
$-3.45 |
0.00 |
| 2013-06-30 |
5120.00 |
$-4.22 |
0.00 |
| 2013-03-31 |
6323.20 |
$-3.80 |
0.00 |
| 2012-12-31 |
6643.20 |
$-4.84 |
0.00 |
| 2012-09-30 |
9369.60 |
$-12.67 |
0.00 |
| 2012-06-30 |
9523.20 |
$-12.03 |
0.00 |
| 2012-03-31 |
11366.40 |
$-12.12 |
0.00 |
| 2011-12-31 |
19200.00 |
$-10.73 |
0.00 |
| 2011-09-30 |
26880.00 |
$-19.67 |
0.00 |
| 2011-06-30 |
37334.00 |
$-21.82 |
0.00 |
| 2011-03-31 |
47923.20 |
$-21.57 |
0.00 |
| 2010-12-31 |
62659.60 |
$-21.29 |
0.00 |
| 2010-09-30 |
55249.90 |
$-5.05 |
0.00 |
| 2010-06-30 |
105118.00 |
$-2.41 |
0.00 |
| 2010-03-31 |
176026.00 |
$-2.26 |
0.00 |
| 2009-12-31 |
227635.00 |
$-2.32 |
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED PRODUCTS |
$0.009B |
$0.003B |
|
Neurometrix is a medical device company establishing a new standard of care through the design, development and sale of proprietary products used to diagnose neuropathies. Neuropathies are diseases of the peripheral nerves and parts of the spine that frequently are caused by or associated with diabetes, low back pain and carpal tunnel syndrome, as well as other clinical disorders.
|
